Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter...

por Allais, G., Tullo, V., Omboni, S., Pezzola, D., Zava, D., Benedetto, C., Bussone, G.
Publicado 2013

Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies

por Allais, G, Tullo, V, Omboni, S, Benedetto, C, Sances, G, Zava, D, Ferrari, MD, Bussone, G
Publicado 2013

Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial

por Allais, G, Bussone, G, Tullo, V, Cortelli, P, Valguarnera, F, Barbanti, P, Sette, G, D’Onofrio, F, Curone, M, Benedetto, C
Publicado 2015

EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura

por Allais, G, Tullo, V, Cortelli, P, Barbanti, P, Valguarnera, F, Sette, G, D'Onofrio, F, Curone, M, Reggiardo, G, Omboni, S, Frediani, F, Bussone, G, Benedetto, C
Publicado 2014